| Literature DB >> 33050561 |
Elena-Suzana Biris-Dorhoi1, Delia Michiu2, Carmen R Pop1, Ancuta M Rotar1, Maria Tofana1, Oana L Pop1, Sonia A Socaci1, Anca C Farcas1.
Abstract
Nowadays, one of the most important research directions that concerns the scientific world is to exploit the earth's resources in a sustainable way. Considering the increasing interest in finding new sources of bioactive molecules and functional products, many research studies focused their interest on demonstrating the sustainability of exploiting marine macroalgal biomass as feedstock for wastewater treatment and natural fertilizer, conversion into green biofuels, active ingredients in pharmaceutical and nutraceutical products, or even for the production of functional ingredients and integration in the human food chain. The objective of the present paper was to provide an overview on the recent progress in the exploitation of different macroalgae species as a source of bioactive compounds, mainly emphasizing the latter published data regarding their potential bioactivities, health benefits, and industrial applications.Entities:
Keywords: antimicrobial; antiproliferative activity; bioactive compounds; bioactivities; macroalgae; polysaccharides
Mesh:
Substances:
Year: 2020 PMID: 33050561 PMCID: PMC7601163 DOI: 10.3390/nu12103085
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1The main applications of macroalgae.
The most used species of algae in food industry and their general characteristics.
|
| Dark brown, to 2 m in length; presents a claw-like holdfast, a smooth, flexible stipe, and also a laminate blade to 1.5 m long split into finger-like segments [ |
| The species is rich in alginates, mannitol, and amino acids. [ | |
| Very rich in iodine; therefore, this seaweed promotes slimming and has antiseptic properties [ | |
|
| Thallus is flat and leaf-like, up to 30 mm long and 5–30 mm broad. The fronds are thin and translucent; colors differ from olive to golden-brown [ |
| Produces large amounts of heterogeneous polysaccharides when submitted to the extraction procedures used to obtain fucoidans [ | |
|
| Thallus fixed by a ramified holdfast [ |
| Rich source of eicosapentaenoic acid, an omega-3 fatty acid, and presents high levels of sodium, calcium, iodine, thiamine, and niacin [ | |
|
| Can be distinguished by its smooth thallus, most with a ruffled margin [ |
| Rich in essential amino acids, fatty acids, vitamins, dietary fiber, and resistant protein [ | |
|
| A perennial brown alga and exists mainly in subtidal areas off the coast of Japan and Korea [ |
| Eckol isolated from | |
| Exhibits radical scavenging activity, but also antiplasmin inhibiting activity, antimutagenic activity, bactericidal activity, human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, and protease inhibition [ |
Figure 2Health effects of macroalgae on human health and wellbeing.
The anti-inflammatory effect of different species of algae.
| Algae Species | Active Extract/Compound | Biological Activity | Reference |
|---|---|---|---|
|
| Methanolic extracts | Anti-inflammatory effect in lipopolysaccharide (LPS) induced mouse RAW 264.7 macrophages cell line. | [ |
|
| Methanolic extracts | Decrease the xylene-induced ear edema and reduce cell migration to different sites. | [ |
|
| Fucoxanthin | LPS-stimulated RAW 264.7 macrophages. | [ |
|
| Methanolic extracts | Carrageenan-induced hind paw edema in rats and peritonitis in acute and chronic inflammatory models. | [ |
|
| Sulfated polysaccharides | Inhibits leukocyte recruitment in rat and the neutrophil adhesion to platelets. | [ |
|
| β-carotene fucoxanthin PUFA | Able to inhibit LPS-induced inflammatory pathways in human macrophages. | [ |
|
| Sulfated polysaccharides | Decrease neutrophils migration. | [ |
|
| Heterofucan | Binds to the surface of leucocytes and inhibits migration of leucocytes to the site of injury. | [ |
|
| Ethanolic extract | Concentration-dependent reduction of LPS-induced prostaglandin E2 production. | [ |
|
| Sulfated polysaccharide fraction | Significantly inhibits rat paw edema induced by different inflammatory agents (carrageenan and dextran, histamine and L-arginin). | [ |
|
| Dc-porphyran | Inhibits nitric oxide (NO) production in LPS-stimulated RAW 264.7 cells. | [ |
|
| Astaxanthin Xanthophyl | Anti-inflammatory action. | [ |
|
| Fucans | Inhibits the paw edema, plasma exudation, nitrite content, and leukocyte migration. | [ |
|
| Carrageenan, Fucoidan, Chondroitin | Lowered the expression of inducible nitric oxide synthase (iNOS). | [ |
|
| Fucoidan | Anti-atopic dermatitis | [ |